5 Analysts Have This to Say About ShockWave Medical
Portfolio Pulse from Benzinga Insights
ShockWave Medical (NASDAQ:SWAV) has received various analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, and 2 indifferent. The average price target is $275.0, compared to the current price of $200.71, implying an upside. However, this average represents a 11.77% decrease from the previous average price target of $311.67.
October 16, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Mixed analyst ratings for ShockWave Medical could lead to uncertainty among investors. The average price target suggests an upside, but it's lower than the previous target.
The mixed analyst ratings indicate differing opinions about the company's performance, which could lead to uncertainty among investors. The average price target suggests potential for growth, but the decrease from the previous target may raise concerns.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100